Cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. Receptor for E.coli Dr adhesins, found in adenocarcinomas of endodermally derived digestive system epithelium and fetal colon. Belongs to the immunoglobulin superfamily, CEA family- contains 7 Ig-like (immunoglobulin-like) domains.
| Inventor | Institute |
|---|---|
| Mike Price | University of Nottingham |
| Cat. #: | 153383 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell signaling and signal transduction |
| Application: | ELISA ; FACS ; IHC |
| Target: | CD66e |
| Reactivity: | Human |
| Clone: | C365D3(NCRC23) |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | CEACAM5; CEA; Carcinoembryonic Antigen |
|---|---|
| Product description: | Cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. Receptor for E.coli Dr adhesins, found in adenocarcinomas of endodermally derived digestive system epithelium and fetal colon. Belongs to the immunoglobulin superfamily, CEA family- contains 7 Ig-like (immunoglobulin-like) domains. |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 84 kDa |
| Immunogen: | CEA |
| Target background: | Cell surface glycoprotein that plays a role in cell adhesion and in intracellular signaling. Receptor for E.coli Dr adhesins, found in adenocarcinomas of endodermally derived digestive system epithelium and fetal colon. Belongs to the immunoglobulin superfamily, CEA family- contains 7 Ig-like (immunoglobulin-like) domains. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Dallas et al. 2012. FASEB J. 26(6):2648-56. PMID: 22415308. Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis. Durrant et al. 1989. J Natl Cancer Inst. 81(9):688-96. PMID: 2468779. Flow cytometric screening of monoclonal antibodies for drug or toxin targeting to human cancer. Durrant et al. 1987. Br J Cancer. 56(4):425-32. PMID: 3689659. Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression. Durrant et al. 1986. Cancer Res. 46(7):3543-9. PMID: 3518917. Association of antigen expression and DNA ploidy in human colorectal tumors. Durrant et al. 1986. Br J Cancer. 53(1):37-45. PMID: 3947514. Antigenicity of newly established colorectal carcinoma cell lines. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151040 | Anti-CD11 & CD18 [24] |
Key Info
Anti-CD11 & CD18 [24]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.